Q3 2025 Earnings Call Transcript November 4, 2025 Taysha Gene Therapies, Inc. misses on earnings expectations. Reported EPS ...

With greater understanding of the complex pathomechanisms of myalgic encephalomyelitis/chronic fatigue syndrome, researchers ...

Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...

CAR T and CAR Treg therapies revolutionize cancer treatment through automation, scalability, and global manufacturing innovation.

Traditional medications are synthesized through chemical reactions, whereas biologics are derived from and reproduced, at ...

The post FDA Feedback Surprises Huntington’s Drug Watchers appeared first on Self Employed.

Pivotal Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First Line (1L) Consolidation in Large B-Cell Lymphoma (LBCL) ALPHA3 ...

A specific genetic detector could offer potential to doctors in reversing damages in the sensory cells of the inner ear, ...

Industry leaders say uncertainty in funding, clinical development and manufacturing is driving companies to embrace digital transformation, streamlined operations and strategic partnerships to ...

HER2DX is a prognostic, predictive assay based on clinical and genomic data. The test integrates clinical information (i.e.

In the fall of 1987, Ronald Reagan was president, Bon Jovi was the breakthrough band of the year, and mullets were still worn ...

Good afternoon, and welcome to Sarepta's Third Quarter 2025 Financial Results Conference Call. As a reminder, today's program is being recorded. At this time, I'll turn the call over to Tam Thornton, ...